Biosynthesis of terpene compounds using the non-model yeast Yarrowia lipolytica: grand challenges and a few perspectives. (August 2020)

• Record Type: Journal Article
• Authors: Worland, Alyssa M; Czajka, Jeffrey J; Li, Yanran; Wang, Yechun; Tang, Yinjie J; Su, Wei Wen
• Is Part Of: Current opinion in biotechnology. Volume 64(2020)
• Page Start: 134
• Page End: 140
• Publication Date: 2020-08
• Subjects: Biotechnology -- Periodicals; 660.6
• DOI: 10.1016/j.copbio.2020.02.020
• Languages: English
• ISSNs: 0958-1669

Abstract

Graphical abstract: Highlights: Yarrowia has shown the potential for producing complex terpenoids. Yarrowia may hold multiple cytosolic acetyl-CoA and NADPH generation pathways. Metabolite channeling is a key consideration in terpene pathway engineering. Knowledge gaps exist in compartment-specific fluxes for utilizing alternative carbon sources (e.g., lipids). Metabolic shift, genetic stability, and dimorphism in large-scale Yarrowia fermentation need further studies. Abstract : Yarrowia lipolytica has emerged as an important non-model host for terpene production. However, three main challenges remain in industrial production using this yeast. First, considerable knowledge gaps exist in metabolic flux across multiple compartments, cofactor generation, and catabolism of non-sugar carbon sources. Second, many enzymatic steps in the complex-terpene synthesis pathway can pose rate-limitations, causing accumulation of toxic intermediates and increased metabolic burdens. Third, metabolic shifts, morphological changes, and genetic mutations are poorly characterized under industrial fermentation conditions. To overcome these challenges, systems metabolic analysis, protein engineering, novel pathway engineering, model-guided strain design, and fermentation optimization have been attempted with some successes. Further developments that address these challenges are needed to advance the Yarrowia lipolytica platform for industrial-scale production of high-value terpenes, including those with highly complex structures such as anticancer molecules withanolides and insecticidal limonoids.